Alector (ALEC) Net Income (2018 - 2026)
Alector (ALEC) posted quarterly Net Income of -$22.9 million for Q1 2026, up 43.34% year-over-year from -$16.0 million in Q1 2025, and up 38.19% quarter-over-quarter from -$37.1 million in Q4 2025.
Alector (ALEC) Net Income (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Net Income for 9 consecutive years, with -$22.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income rose 43.34% year-over-year to -$22.9 million; the TTM figure through Mar 2026 stood at -$125.2 million (down 1.44% YoY), while the FY2025 annual figure was -$142.8 million, down 19.92% from the prior year.
- Net Income grew to -$22.9 million in Q1 2026 per ALEC's latest filing, from -$37.1 million in the prior quarter.
- Across five years, Net Income topped out at $9.9 million in Q2 2022 and bottomed at -$52.4 million in Q4 2022.
- Historically, Net Income has averaged -$31.9 million across 5 years, with a median of -$37.1 million in 2025.
- Annual changes were most pronounced in 2022 — Net Income soared 117.92% — and 2024, when it tumbled 2912.8%.
- Alector's Net Income stood at -$52.4 million in 2022, then surged by 31.73% to -$35.8 million in 2023, then jumped by 94.21% to -$2.1 million in 2024, then tumbled by 1688.77% to -$37.1 million in 2025, then jumped by 38.19% to -$22.9 million in 2026.
- Business Quant data shows ALEC's Net Income at -$22.9 million in Q1 2026, -$37.1 million in Q4 2025, and -$34.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 930.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -22.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.99 Mn |
| Mar 31, 2026 | -22.93 Mn |
| Dec 31, 2025 | -37.10 Mn |
| Sep 30, 2025 | -34.67 Mn |
| Jun 30, 2025 | -30.52 Mn |
| Mar 31, 2025 | -40.47 Mn |
| Dec 31, 2024 | -2.07 Mn |
| Sep 30, 2024 | -42.22 Mn |
| Jun 30, 2024 | -38.68 Mn |
| Mar 31, 2024 | -36.08 Mn |
| Dec 31, 2023 | -35.79 Mn |
| Sep 30, 2023 | -44.48 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | -45.86 Mn |
| Dec 31, 2022 | -52.43 Mn |
| Sep 30, 2022 | -46.15 Mn |
| Jun 30, 2022 | 9.88 Mn |
| Mar 31, 2022 | -44.62 Mn |
| Dec 31, 2021 | -47.98 Mn |
| Sep 30, 2021 | 126.60 Mn |